- Home
- DRTS vs CYRX Comparison
DRTS vs CYRX Comparison
Compare DRTS & CYRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DRTS | CYRX |
|---|---|---|
| Founded | 2015 | 1999 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 445.1M | 472.7M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | DRTS | CYRX |
|---|---|---|
| Price | $7.64 | $11.24 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 9 |
| Target Price | $8.00 | ★ $12.83 |
| AVG Volume (30 Days) | 319.3K | ★ 360.1K |
| Earning Date | 11-20-2025 | 03-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 1.27 |
| Revenue | N/A | ★ $243,795,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $9.26 |
| P/E Ratio | ★ N/A | $8.62 |
| Revenue Growth | N/A | ★ 41.27 |
| 52 Week Low | $2.30 | $4.58 |
| 52 Week High | $7.89 | $11.44 |
Technical Indicators
Market Signals| Indicator | DRTS | CYRX |
|---|---|---|
| Relative Strength Index (RSI) | 78.12 | 75.22 |
| Support Level | $6.45 | $10.32 |
| Resistance Level | $5.14 | $10.99 |
| Average True Range (ATR) | 0.50 | 0.42 |
| MACD | 0.20 | 0.12 |
| Stochastic Oscillator | 92.04 | 98.40 |
Price Performance
Historical ComparisonAbout DRTS Alpha Tau Medical Ltd.
Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as localized radiation therapy for solid tumors. Its proprietary Alpha DaRT technology is designed to utilize the specific therapeutic properties of alpha particles while aiming to overcome, and even harness for potential benefit, the traditional shortcomings of alpha radiation's limited range. The company derives maximum revenue from Israel.
About CYRX CryoPort Inc.
CryoPort Inc is a leader serving the life sciences industry as a provider of integrated temperature-controlled supply chain solutions supporting the life sciences in the biopharma/pharma, animal health, and reproductive medicine markets. It operates in two reportable segments: Life Sciences Services and Life Sciences Products. Geographically the company operates in the Americas, Europe, the Middle East and Africa (EMEA), and Asia Pacific (APAC), generating a majority of its revenue from the Americas.